The latest from EthiQal

For TimesLive by Sanet Oberholzer Last week a High Court order ruled that ivermectin, the contentious anti-parasitic drug that has harnessed much attention for its potential ability to suppress COVID-19

The COVID-19 pandemic has brought about worldwide economic, social and medical uncertainty. For doctors, this uncertainty extends to whether new treatments will be beneficial to patients in protecting them from

When applying for any type of insurance cover, insurers typically ask a set of questions that allows for evaluation of the risk to be protected. This forms part of underwriting –

Medical insurer eyes rapid growth in burgeoning local malpractice insurance market.For Business Day by Garth Theunissen EthiQal, the medical professional indemnity division of Conduit Capital-owned Constantia Insurance, plans to double